Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

NCT05784441

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • University of Iowa Hospital Iowa City, Iowa, United States
  • University of Kentucky Lexington, Kentucky, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Rutgers University New Brunswick, New Jersey, United States
View all 15 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

NCT06425302

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Local Institution - 0152 Birmingham, Alabama, United States
  • Local Institution - 0055 Anchorage, Alaska, United States
  • Local Institution - 0180 Phoenix, Arizona, United States
  • Local Institution - 0190 Tucson, Arizona, United States
View all 56 locations
View Trial Details
Active, not recruiting

A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

NCT07030517

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • M S Ramaiah Medical College and Hospital Bangalore, India
  • St. Johns Medical College And Hospital Bengaluru, India
  • Post Graduate Institute of Medical Education And Research PGIMER Chandigarh, India
  • Bhagwan Mahaveer Cancer Hospital & Research Centre Jaipur, India
View Trial Details
Active, not recruiting

A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

NCT06470438

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Sun Yat Sen University Cancer Center Guangzhou, China
  • The First Affiliated Hospital Zhejiang University College of Medicine Hangzhou, China
  • Fudan University Shanghai Cancer Center Shanghai, China
View all 19 locations
View Trial Details
Active, not recruiting

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

NCT00114101

Conditions
Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Multiple Myeloma, +19 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Diego Medical Center - Hillcrest San Diego, California, United States
View all 140 locations
View Trial Details
Active, not recruiting

Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

NCT04652960

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
View all 17 locations
View Trial Details
Active, not recruiting

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

NCT05963074

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • The Oncology Institute Clinical Research Cerritos, California, United States
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
  • SLO Oncology and Hematology Health Center San Luis Obispo, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
View all 74 locations
View Trial Details
Active, not recruiting

Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma

NCT04458922

Conditions
Central Chondrosarcoma, Grade 2, Central Chondrosarcoma, Grade 3, Dedifferentiated Chondrosarcoma, +17 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
View all 15 locations
View Trial Details

Related conditions